Literature DB >> 19360385

[Depression in restless legs syndrome. Pathogenesis, assessment, and implications for treatment].

M Hornyak1, H Benes, I Eisensehr, J Haan, J Kassubek, I Peglau, K Stiasny-Kolster, C Trenkwalder.   

Abstract

Depressive disorders are a prevalent comorbidity in restless legs syndrome (RLS). Although similar prevalence rates of comorbid depression can be found in other diseases, the association between RLS and depression is particularly complex due to the RLS-related sleep disorders. It is also clinically important that according to findings derived mainly from case studies many antidepressant agents can aggravate RLS symptoms. The presence of comorbid depression influences therapy outcome in general and should therefore be taken into account. So far, there is no evidence-based systematic research concerning diagnosis and treatment process, and no recommendations exist for the treatment of affective disorders in RLS. In the present work, the clinical relevance of depression in RLS and antidepressive treatment in RLS symptoms is discussed and a therapeutic algorithm (evidence level C) for the treatment of depression in RLS is provided.

Entities:  

Mesh:

Year:  2009        PMID: 19360385     DOI: 10.1007/s00115-009-2710-8

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  24 in total

1.  Restless legs syndrome prevalence and impact: REST general population study.

Authors:  Richard P Allen; Arthur S Walters; Jacques Montplaisir; Wayne Hening; Andrew Myers; Timothy J Bell; Luigi Ferini-Strambi
Journal:  Arch Intern Med       Date:  2005-06-13

Review 2.  Treatment of depression in patients with restless legs syndrome: what is evidence-based?

Authors:  Magdolna Hornyak; Ulrich Voderholzer; Dieter Riemann
Journal:  Sleep Med       Date:  2006-03-27       Impact factor: 3.492

3.  Bupropion may improve restless legs syndrome: a report of three cases.

Authors:  Sung-Wan Kim; Il-Seon Shin; Jae-Min Kim; Su-Jin Yang; Hee-Young Shin; Jin-Sang Yoon
Journal:  Clin Neuropharmacol       Date:  2005 Nov-Dec       Impact factor: 1.592

4.  Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome.

Authors:  Magdolna Hornyak; Marta Kopasz; Mathias Berger; Dieter Riemann; Ulrich Voderholzer
Journal:  J Clin Psychiatry       Date:  2005-09       Impact factor: 4.384

5.  "Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome.

Authors:  J Winkelmann; M Prager; R Lieb; H Pfister; B Spiegel; H-U Wittchen; F Holsboer; C Trenkwalder; A Ströhle
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

Review 6.  [Anhedonia--a general nosology surmounting correlate of a dysfunctional dopaminergic reward system?].

Authors:  A Heinz
Journal:  Nervenarzt       Date:  1999-05       Impact factor: 1.214

7.  Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults.

Authors:  N Breslau; T Roth; L Rosenthal; P Andreski
Journal:  Biol Psychiatry       Date:  1996-03-15       Impact factor: 13.382

8.  Marked reduction in indexes of dopamine metabolism among patients with depression who attempt suicide.

Authors:  A Roy; F Karoum; S Pollack
Journal:  Arch Gen Psychiatry       Date:  1992-06

Review 9.  Restless legs syndrome: an update on treatment options.

Authors:  Anthony H V Schapira
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Cognitive behavioural group therapy to improve patients' strategies for coping with restless legs syndrome: a proof-of-concept trial.

Authors:  M Hornyak; C Grossmann; R Kohnen; M Schlatterer; H Richter; U Voderholzer; D Riemann; M Berger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-02-26       Impact factor: 10.154

View more
  5 in total

1.  Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study.

Authors:  Heike Benes; Wolfgang Mattern; Ines Peglau; Tillmann Dreykluft; Lars Bergmann; Corinna Hansen; Ralf Kohnen; Norbert Banik; S W Schoen; Magdolna Hornyak
Journal:  J Neurol       Date:  2010-12-28       Impact factor: 4.849

2.  [Sleep medicine differential diagnostics in psychiatry and psychotherapy].

Authors:  T Pollmächer; T C Wetter; S Happe; K Richter; J Acker; D Riemann
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

3.  Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management.

Authors:  Magdolna Hornyak
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

4.  A double-blind, randomized, controlled trial to compare the efficacy and tolerability of fixed doses of ropinirole, bupropion, and iron in treatment of restless legs syndrome (Willis-Ekbom disease).

Authors:  Kirti Vishwakarma; Juhi Kalra; Ravi Gupta; Mukesh Sharma; Taruna Sharma
Journal:  Ann Indian Acad Neurol       Date:  2016 Oct-Dec       Impact factor: 1.383

5.  Sleep disturbances and suicidality: a common association to look for in clinical practise and preventive care.

Authors:  Christine Norra; Nadja Richter; Georg Juckel
Journal:  EPMA J       Date:  2011-07-23       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.